Kromek, the Newcastle-based radiation and bio-technology development company, has received a new biosecurity award from the UK Ministry of Defence (MoD), along with other orders in the CBRN Detection segment worth a total of £860,000.
The company has been awarded a contract from the UK MoD’s Defence Science and Technology Laboratory to develop new methods for enhancing the detection of biological agents and incidents. Kromek has been awarded £250,000 for the 18-month project, which is being funded through the UK Government’s Defence and Security Accelerator.
This new contract complements Kromek’s existing multi-year agreements for the development of biological-threat detection systems with a UK Government department and the US Department of Homeland Security.
The listed firm has also received several orders from global customers in the nuclear security segment. This includes an order totalling $470,000 (£349,210) for its D5 detectors under a pre-existing Indefinite Delivery, Indefinite Quantity (IDIQ) contract. This contract was originally announced in April 2024, and to date, the group has received orders of $1.9 million (£1.41 million), with up to $1.0 million (£743,000) remaining to be ordered before the programme’s expiry.
The business has also received three orders, totalling £252,000, for its D3M detectors from distributors for end customers in Japan, Canada, and Bulgaria.
Arnab Basu, CEO of Kromek, said: “These latest CBRN detection orders from both public and private sector customers across the UK, US, Japan, Canada and Bulgaria underscore the global demand for our mission-critical solutions and the broad, growing base of organisations that rely on our technology. We are especially proud to have been awarded a new biosecurity contract by the UK Ministry of Defence, expanding our existing collaboration in nuclear security and reinforcing our position as a trusted partner in national defence. These orders provide increased visibility on our future revenue and reflect the strong momentum building in this segment. We look forward to reporting further progress as we continue to scale and deliver on our strategy.”
Image source: Kromek
